Pelthos Therapeutics (PTHS) EPS (Basic) Growth (3y) (2026)
Powered by 
Analysis
Pelthos Therapeutics (PTHS) EPS (Basic) Growth (3y) (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.98 Bn | 621.22 Bn | 17.26 Bn | 5.11% |
| 2 | AbbVie | 446.60 Bn | 440.03 Bn | 12.70 Bn | 21.23% |
| 3 | Merck | 357.75 Bn | 350.61 Bn | 12.21 Bn | 38.72% |
| 4 | Novartis Ag | 267.43 Bn | 259.74 Bn | 11.24 Bn | 14.72% |
| 5 | Pfizer | 156.61 Bn | 144.91 Bn | 10.94 Bn | -28.08% |
| 6 | Sanofi | 52.22 Bn | 44.84 Bn | 10.79 Bn | -36.03% |
| 7 | Revolution Medicines | 42.95 Bn | 42.95 Bn | - | - |
| 8 | Incyte | 24.57 Bn | 20.04 Bn | 1.57 Bn | 47.44% |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | 12.25% |
| 10 | Pelthos Therapeutics | 80.13 Mn | 55.57 Mn | 21.23 Mn | -12.95% |